Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001193125-26-285505

Chief Financial Officer sold 2,362 shares at $20.37 ($48,114)

From the SEC's structured data for this filing

Trades in this filing

Lucera Erick · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-06-25 Sale : show line 1 in the form −2,362 $20.37 $48,114 121,563 D
Open-market sales · 2,362 sh · avg $20.37 · $48,114
Loading xslF345X06/ownership.xml…